Previous close | 69.63 |
Open | 69.82 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's range | 68.38 - 70.21 |
52-week range | 64.41 - 83.25 |
Volume | |
Avg. volume | 9,758,901 |
Market cap | 86.343B |
Beta (5Y monthly) | 0.51 |
PE ratio (TTM) | 10.59 |
EPS (TTM) | 6.47 |
Earnings date | 01 May 2024 |
Forward dividend & yield | 2.66 (3.88%) |
Ex-dividend date | 19 Apr 2024 |
1y target est | 81.36 |
Baum Family Investments (BFI) proudly announces its official debut in the real estate investment landscape. With over fifteen years of expertise in triple net leased investments and the backing of prominent family offices in Detroit, Miami, and New York, BFI enters the market poised for success.
The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
In the most recent trading session, CVS Health (CVS) closed at $69.75, indicating a +0.52% shift from the previous trading day.